<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>earnings report on FinanClub</title>
    <link>https://finan.club/tags/earnings-report/</link>
    <description>Recent content in earnings report on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 18 Aug 2023 10:29:13 +0000</lastBuildDate><atom:link href="https://finan.club/tags/earnings-report/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MPW</title>
      <link>https://finan.club/us/mpw/</link>
      <pubDate>Fri, 18 Aug 2023 10:29:13 +0000</pubDate>
      
      <guid>https://finan.club/us/mpw/</guid>
      <description>score:111
Chances: Medical Properties Trust has announced the sale of a significant interest in Steward Health Care System&amp;rsquo;s credit facility, which could indicate strategic financial moves. Despite the pitfalls, there might be investment opportunities for dividend investors in Medical Properties Trust due to the company&amp;rsquo;s high yield.</description>
    </item>
    
    <item>
      <title>M</title>
      <link>https://finan.club/us/m/</link>
      <pubDate>Fri, 18 Aug 2023 10:28:36 +0000</pubDate>
      
      <guid>https://finan.club/us/m/</guid>
      <description>score:75
Chances: Macy&amp;rsquo;s is set to report earnings, which could provide insights into the company&amp;rsquo;s financial performance. The appointment of Massimo Magni as chief customer and digital officer could signal a focus on digital transformation and customer engagement. Macy&amp;rsquo;s back-to-school season offerings and efforts to provide a unique shopping experience could drive customer engagement and sales.</description>
    </item>
    
    <item>
      <title>XOM</title>
      <link>https://finan.club/us/xom/</link>
      <pubDate>Fri, 18 Aug 2023 09:51:06 +0000</pubDate>
      
      <guid>https://finan.club/us/xom/</guid>
      <description>score:-22
Chances: Exxon Mobil Corporation (XOM) experienced a gain of 2.3% in mid-afternoon trading due to higher oil prices, contributing to positive investor sentiment. An in-depth evaluation of Exxon Mobil&amp;rsquo;s valuation, financial strength, profitability, and growth could provide insights into the company&amp;rsquo;s potential.</description>
    </item>
    
    <item>
      <title>XPEV</title>
      <link>https://finan.club/us/xpev/</link>
      <pubDate>Fri, 18 Aug 2023 09:47:21 +0000</pubDate>
      
      <guid>https://finan.club/us/xpev/</guid>
      <description>score:26
Chances: XPeng Inc. (XPEV) is an electric vehicle (EV) startup with a growing presence in the Chinese EV market. The company is preparing to report its second-quarter earnings, and Wall Street expects sales of $707 million, which would be a significant year-over-year growth.</description>
    </item>
    
    <item>
      <title>LAZR</title>
      <link>https://finan.club/us/lazr/</link>
      <pubDate>Sat, 12 Aug 2023 06:53:05 +0000</pubDate>
      
      <guid>https://finan.club/us/lazr/</guid>
      <description>score:174
Chances: Luminar reported Q2 2023 results in line with expectations and maintains full-year financial guidance. Luminar delivered positive earnings and revenue surprises for the quarter ended June 2023. The company&amp;rsquo;s partnerships with automakers like Polestar and Nissan indicate growth prospects. Luminar&amp;rsquo;s focus on advanced semiconductor capabilities and AI technologies is positioning it well.</description>
    </item>
    
    <item>
      <title>LU</title>
      <link>https://finan.club/us/lu/</link>
      <pubDate>Sat, 12 Aug 2023 05:40:40 +0000</pubDate>
      
      <guid>https://finan.club/us/lu/</guid>
      <description>score:12
Chances: Lufax Holding is a leading financial services enabler for small business owners in China. Lufax reported unaudited financial results for Q1 2023 with positive earnings and revenue surprises. Change in non-executive director and appointments within the company&amp;rsquo;s board. Risks: Lufax reported an 86% YoY decline in profit for Q1 2023 due to China&amp;rsquo;s lackluster economic recovery.</description>
    </item>
    
    <item>
      <title>APLS</title>
      <link>https://finan.club/us/apls/</link>
      <pubDate>Sat, 12 Aug 2023 05:34:48 +0000</pubDate>
      
      <guid>https://finan.club/us/apls/</guid>
      <description>score:-69
Chances: Apellis Pharmaceuticals reported better-than-expected second-quarter 2023 results, indicating strong performance in its financials. Positive data on SYFOVRE&amp;rsquo;s reduction of nonsubfoveal GA lesion growth could reflect the potential effectiveness of Apellis&amp;rsquo; products. Equity awards granted to new employees could attract and incentivize talented individuals to join the company, contributing to its growth.</description>
    </item>
    
    <item>
      <title> NET</title>
      <link>https://finan.club/us/net/</link>
      <pubDate>Tue, 08 Aug 2023 07:25:33 +0000</pubDate>
      
      <guid>https://finan.club/us/net/</guid>
      <description>score:1022
Chances: Cloudflare&amp;rsquo;s Q2 2023 earnings report showed a 32% YoY revenue increase to $308 million, leading to an 8% jump in stock price. Cloudflare reported positive adjusted operating income and free cash flow in Q2 2023. Cloudflare raised its full-year 2023 outlook and exceeded estimates in its second-quarter results.</description>
    </item>
    
    <item>
      <title> GILD</title>
      <link>https://finan.club/us/gild/</link>
      <pubDate>Tue, 08 Aug 2023 07:17:02 +0000</pubDate>
      
      <guid>https://finan.club/us/gild/</guid>
      <description>score:724
Chances: Gilead Sciences expects a third of sales to come from its cancer treatments by 2030, driving optimism and stock price movement. Gilead Sciences is focused on developing therapies for life-threatening infectious diseases and expanding its portfolio to include pulmonary, cardiovascular diseases, and cancer treatments.</description>
    </item>
    
  </channel>
</rss>
